Evidence map›Paper›PMID 15453912›Full record

Trial reportBMC neurology2004

Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].

Anton C van de Vusse, Suzanne G M Stomp-van den Berg, Alfons H F Kessels, Wim E J Weber

Registry-linked trialOpen access · goldAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in BMC neurology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01623271 (Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin), which is not on this map. Cited by 62 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 7 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01623271 naterminatednot on this mapstarted 2013, after this paper: background citation

Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)

TypeinterventionalSponsorMassachusetts General HospitalRan2013 to 2014Enrolled5ConditionsComplex Regional Pain Syndrome I (CRPS I)ArmsGabapentin
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 7 syntheses or guidelines pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Gabapentin for chronic neuropathic pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Pooled it
  4. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Pooled it
  6. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.The Cochrane database of systematic reviews · 2011
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Management of Neuropathic Pain in Complex Regional Pain Syndrome: A Comprehensive Review.Pain practice : the official journal of World Institute of Pain · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. 10. Complex regional pain syndrome.Pain practice : the official journal of World Institute of Pain · 2025
    Review
  18. Review
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anton C van de VussePain Management and Research Centre, Dept. of Anesthesiology, University Hospital Maastricht, Maastricht, The Netherlands. vandevusse@doctor.com <vandevusse@doctor.com>
Suzanne G M Stomp-van den Berg
Alfons H F Kessels
Wim E J Weber
Maastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplex Regional Pain Syndrome type one (CRPS I) or formerly Reflex Sympathetic Dystrophy (RSD) is a disabling syndrome, in which a painful limb is accompanied by varying symptoms. Neuropathic pain is a prominent feature of CRPS I, and is often refractory to treatment. Since gabapentin is an anticonvulsant with a proven analgesic effect in various neuropathic pain syndromes, we sought to study the efficacy of the anticonvulsant gabapentin as treatment for pain in patients with CRPS I.

methodsWe did a randomized double blind placebo controlled crossover study with two three-weeks treatment periods with gabapentin and placebo separated by a two-weeks washout period. Patients started at random with gabapentin or placebo, which was administered in identical capsules three times daily. We included 58 patients with CRPS type 1.

resultsPatients reported significant pain relief in favor of gabapentin in the first period. Therapy effect in the second period was less; finally resulting in no significant effect combining results of both periods. The CRPS patients had sensory deficits at baseline. We found that this sensory deficit was significantly reversed in gabapentin users in comparison to placebo users.

conclusionsGabapentin had a mild effect on pain in CRPS I. It significantly reduced the sensory deficit in the affected limb. A subpopulation of CRPS patients may benefit from gabapentin.

Indexed as

AdultAgedAminesAnalgesicsCross-Over StudiesCyclohexanecarboxylic AcidsDouble-Blind MethodFemaleGabapentingamma-Aminobutyric AcidHumansMaleMiddle AgedPainPain MeasurementReflex Sympathetic DystrophyAminesAnalgesicsCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric Acid

Identifiers

PMID15453912
PMCPMC523854
OpenAlexW2115793894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.